Supplier name: Flexipharm Austrading Limited
Publication date: February 2025
http://www.flexipharmaustrading.com/
Commitment to achieving Net Zero
Flexipharm Austrading Limited is committed to achieving Net Zero emissions by 2045.
Baseline Emissions Footprint
Current Emissions Reporting
Emissions reduction targets
Flexipharm Austrading Limited was committed to a 10% reduction in baseline emissions between the years 2023 and 2024, this they actually achieved with a 10.1% reduction.
Flexipharm Austrading Limited will endeavour to continue this with other initiatives in 2025. This however will be dependent on stock required to fulfil NHS contracts awarded for our current medicines, along with any new medicines we launch in 2025 and future years.
We project that carbon emissions will decrease over the next five years to 10.5 tCO2e by 2028. This is a reduction of 17%.
Progress against these targets can be seen in the graph below:
Carbon Reduction Projects
Completed Carbon Reduction Initiatives
The following environmental management measures and projects will be initiated throughout 2024 and into 2025 and will continue through the lifetime of the commitment to net zero, along with new initiatives when required:
Declaration and Sign Off
This Carbon Reduction Plan has been completed in accordance with PPN 06/21 and associated guidance and reporting standard for Carbon Reduction Plans.
Emissions have been reported and recorded in accordance with the published reporting standard for Carbon Reduction Plans and the GHG Reporting Protocol corporate standard1 and uses the appropriate Government emission conversion factors for greenhouse gas company reporting2.
Scope 1 and Scope 2 emissions have been reported in accordance with SECR requirements, and the required subset of Scope 3 emissions have been reported in accordance with the published reporting standard for Carbon Reduction Plans and the Corporate Value Chain (Scope 3) Standard3.
This Carbon Reduction Plan has been reviewed and signed off by the board of directors (or equivalent management body).
Signed on behalf of the Supplier:
Name: Michael Clark
Date: 20 March 2025
References:
1. https://ghgprotocol.org/corporate-standard
2. https://www.gov.uk/government/collections/government-conversion-factors-for-company-reporting
3. https://ghgprotocol.org/standards/scope-3-standard